GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC-COA-0000019/2026

Guardant Health, Inc. v. Sophia Genetics SA, Sophia Genetics SAS, Sophia Genetics SRL, Sophia Genetics GmbH

Datum
2026-02-18
Kammer
Luxembourg (LU)
Verfahrensart
Application Rop 223
Sprache
EN

Metadaten

Fall-IDUPC-COA-0000019-2026-ea38820c23b7
AktenzeichenUPC-COA-0000019/2026
RegisterzeichenUPC-COA-0000019/2026
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 6

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 18 February 2026 Application for suspensive effect (R. 223 RoP) APPLICANT AND APPELLANT (APPLICANT BEFORE THE COURT OF FIRST INSTANCE) Guardant Health, Inc., Palo Alto, California, United States of America (hereinafter: “Guardant”) represented by attorney at law Agathe Michel -De Cazotte , Carpmaels & Ransford LLP, London, United Kingdom RESPONDENTS (AND DEFENDANTS BEFORE THE COURT OF FIRST INSTANCE) 1. Sophia Genetics SA, Rolle, Switzerland 2. Sophia Genetics SAS, Bidart, France 3. Sophia Genetics SRL, Milan, Italy 4. Sophia Genetics GmbH, Freiburg, Germany (hereinafter: “Sophia”) represented by attorneys at law Liz Cohen and other representatives from Bristows (Ireland) LLP, Dublin, Ireland PATENT AT ISSUE EP 3 443 066  ...